These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Role of the pituitary-bone axis in skeletal pathophysiology. Imam A; Iqbal J; Blair HC; Davies TF; Huang CL; Zallone A; Zaidi M; Sun L Curr Opin Endocrinol Diabetes Obes; 2009 Dec; 16(6):423-9. PubMed ID: 19816170 [TBL] [Abstract][Full Text] [Related]
25. Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption. Cawley KM; Bustamante-Gomez NC; Guha AG; MacLeod RS; Xiong J; Gubrij I; Liu Y; Mulkey R; Palmieri M; Thostenson JD; Goellner JJ; O'Brien CA Cell Rep; 2020 Sep; 32(10):108052. PubMed ID: 32905775 [TBL] [Abstract][Full Text] [Related]
26. The pathophysiology of immunoporosis: innovative therapeutic targets. Ferbebouh M; Vallières F; Benderdour M; Fernandes J Inflamm Res; 2021 Aug; 70(8):859-875. PubMed ID: 34272579 [TBL] [Abstract][Full Text] [Related]
27. Metabolic Health and Disease: A Role of Osteokines? Shimonty A; Bonewald LF; Huot JR Calcif Tissue Int; 2023 Jul; 113(1):21-38. PubMed ID: 37193929 [TBL] [Abstract][Full Text] [Related]
28. Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. Cheng CH; Chen LR; Chen KH Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163300 [TBL] [Abstract][Full Text] [Related]
29. Bone Homeostasis and Gut Microbial-Dependent Signaling Pathways. Zhong X; Zhang F; Yin X; Cao H; Wang X; Liu D; Chen J; Chen X J Microbiol Biotechnol; 2021 Jun; 31(6):765-774. PubMed ID: 34176870 [TBL] [Abstract][Full Text] [Related]
30. USP53 Regulates Bone Homeostasis by Controlling Rankl Expression in Osteoblasts and Bone Marrow Adipocytes. Hariri H; Kose O; Bezdjian A; Daniel SJ; St-Arnaud R J Bone Miner Res; 2023 Apr; 38(4):578-596. PubMed ID: 36726200 [TBL] [Abstract][Full Text] [Related]
31. BMP-induced Atoh8 attenuates osteoclastogenesis by suppressing Runx2 transcriptional activity and reducing the Rankl/Opg expression ratio in osteoblasts. Yahiro Y; Maeda S; Morikawa M; Koinuma D; Jokoji G; Ijuin T; Komiya S; Kageyama R; Miyazono K; Taniguchi N Bone Res; 2020; 8(1):32. PubMed ID: 32923015 [TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms in coupling of bone formation to resorption. Martin T; Gooi JH; Sims NA Crit Rev Eukaryot Gene Expr; 2009; 19(1):73-88. PubMed ID: 19191758 [TBL] [Abstract][Full Text] [Related]
33. Exosomes and Extracellular RNA in Muscle and Bone Aging and Crosstalk. Qin W; Dallas SL Curr Osteoporos Rep; 2019 Dec; 17(6):548-559. PubMed ID: 31741222 [TBL] [Abstract][Full Text] [Related]
34. Membrane trafficking in osteoblasts and osteoclasts: new avenues for understanding and treating skeletal diseases. Zhao H Traffic; 2012 Oct; 13(10):1307-14. PubMed ID: 22759194 [TBL] [Abstract][Full Text] [Related]
35. Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts. Ryan JW; Reinke D; Kogawa M; Turner AG; Atkins GJ; Anderson PH; Morris HA Curr Drug Targets; 2013 Dec; 14(14):1683-8. PubMed ID: 24010964 [TBL] [Abstract][Full Text] [Related]
36. [The regulation of various organs by osteoblasts]. Sato S; Takeda S Clin Calcium; 2016 May; 26(5):721-7. PubMed ID: 27117618 [TBL] [Abstract][Full Text] [Related]
37. Involvement of bone in systemic endocrine regulation. Zofkova I Physiol Res; 2018 Nov; 67(5):669-677. PubMed ID: 30044111 [TBL] [Abstract][Full Text] [Related]
38. The role of osteocytes in targeted bone remodeling: a mathematical model. Graham JM; Ayati BP; Holstein SA; Martin JA PLoS One; 2013; 8(5):e63884. PubMed ID: 23717504 [TBL] [Abstract][Full Text] [Related]
39. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nakashima T; Hayashi M; Fukunaga T; Kurata K; Oh-Hora M; Feng JQ; Bonewald LF; Kodama T; Wutz A; Wagner EF; Penninger JM; Takayanagi H Nat Med; 2011 Sep; 17(10):1231-4. PubMed ID: 21909105 [TBL] [Abstract][Full Text] [Related]
40. Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand. Yamamoto Y; Udagawa N; Matsuura S; Nakamichi Y; Horiuchi H; Hosoya A; Nakamura M; Ozawa H; Takaoka K; Penninger JM; Noguchi T; Takahashi N Endocrinology; 2006 Jul; 147(7):3366-74. PubMed ID: 16627581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]